Cobalt(II) oxide
1307-96-6[O]=[Co]IVMYJDGYRUAWML-UHFFFAOYSA-NCobalt (II) Oxide can cause cancer according to The World Health Organization's International Agency for Research on Cancer (IARC).
1307-96-65.7-6.7 depending on preparation
Relative density: 6.66 at 21.3 °C (OECD Guideline 109 (Density of Liquids and Solids))
5.7-6.7 g/cm³
6.45 @25 °C
Powder or cubic or hexagonal crystals; color varies from olive green to red depending on particle size, but the commercial material is usually dark gray
Gray cubic crystals
Grayish powder under most conditiond; can form green brown crystals.
Black to green crystals or powder
In water, 4.88 mg/L at 20 °C, 3.27 mg/L at 37 °C (column elution method)
Practically insoluble in water
Insoluble in water
Soluble in acids or alkalies
Insoluble in ammonium hydroxide; soluble in acids and alkali hydroxides
Solubility in water: none
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H351: Suspected of causing cancer [Warning Carcinogenicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
Danger
H301: Toxic if swallowed [Danger Acute toxicity, oral]
P203, P233, P260, P261, P264, P270, P271, P272, P280, P284, P301+P316, P302+P352, P304+P340, P308+P316, P318, P319, P321, P330, P333+P317, P342+P316, P362+P364, P403, P405, and P501 (click each P-code to see the statement)
Chemical: Cobalt oxide (CoO)
Hazard Traits - Carcinogenicity
Cobalt oxide (CoO) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Cobalt oxide (CoO) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
Cobalt oxide (CoO): Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Trace minerals added to animal feeds. These substances added to animal feeds as nutritional dietary supplements are generally recognized as safe when added at levels consistent with good feeding practice. All substances listed may be in anhydrous or hydrated form. Cobalt oxide is included on this list.
The aim of this study was to find out the intracellular signaling transduction pathways involved in cobalt oxide nanoparticles (CoO NPs) mediated oxidative stress in vitro and in vivo system. Cobalt oxide nanoparticles released excess Co++ ions which could activated the NADPH oxidase and helps in generating the reactive oxygen species (ROS). Our results showed that CoO NPs elicited a significant (p<0.05) amount of ROS in lymphocytes. In vitro pretreatment with N-acetylene cystine had a protective role on lymphocytes death induced by CoO NPs. In vitro and in vivo results showed the elevated level of TNF-alpha after CoO NPs treatment. This TNF-alpha phosphorylated the p38 mitogen-activated protein kinase followed by activation of caspase 8 and caspase 3 which could induce cell death. This study showed that CoO NPs induced oxidative stress and activated the signaling pathway of TNF-alpha-caspase-8-p38-caspase-3 to primary immune cells. This study suggested that bare CoO NPs are a toxic for primary human immune cells that deals directly with human health. Surface modification or surface functionalization may open the gateway for further use of CoO NPs in different industrial use or in biomedical sciences. /Cobalt oxide nanoparticles/
Chest counting data have been collected for about 4 yr for a case which involved inhalation of (60)Co-oxide. The measured chest burden ... decreases with successively increasing half times (about 10 months at early times to about 30 months after 3 yr)... With the exception of the long-term fraction in the lymph nodes, only one rate of elimination seems to be present, 225 days, throughout the period of observation.
The behavior of (60)Co has been studied in 5 men for periods of up to 11 yr after accidental inhalation of the irradiated metal or its oxide. It is concluded from body radioactivity measurements that long term clearance from the chest may be extremely slow, with observed biological half lives of up to 17 yr, while for the clearance of systemic burdens of (60)Co, a value in the region of 7 yr is suggested.
Intratracheally instilled cobaltous oxide (1.5 ug) was retained in the lung for a relatively long period with a half-time of about 15 days.
About 1935 °C
1935 °C
1830 °C
Dry Powder; Large Crystals; CBI
Solid that is dark gray (commercial product), olive green, or red; [Merck Index] Green powder, insoluble in water; [MSDSonline]
BLACK-TO-GREEN CRYSTALS OR POWDER.
When cobalt oxide is reduced with ammonia so that it contains 14-16% /molecular oxygen O2/, it glows when exposed to air. [
Standard enthalpy of formation: -237.9 kJ/mol; heat capacity: 55.2 J/mol K
The commercial cobalt oxides are not usually definite chemical compounds, but are mixtures of two or more cobalt oxides.
Dissolution in water varied from 0.602 mg/L to 32.825 mg/L at about 21-22 °C depending upon concentration loading (1-100 mg/L), time-period (7-28 days) and pH (between 5 and 7)
Listed as a hazardous air pollutant (HAP) generally known or suspected to cause serious health problems. The Clean Air Act, as amended in 1990, directs EPA to set standards requiring major sources to sharply reduce routine emissions of toxic pollutants. EPA is required to establish and phase in specific performance based standards for all air emission sources that emit one or more of the listed pollutants. Cobaltous oxide is included on this list.
Fresh air, rest. Refer for medical attention.
Remove contaminated clothes. Rinse and then wash skin with water and soap.
First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.
Rinse mouth.
Suitable extinguishing media: Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Advice for firefighters: Wear self-contained breathing apparatus for firefighting if necessary.
ACCIDENTAL RELEASE MEASURES: Personal precautions, protective equipment and emergency procedures: Wear respiratory protection. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust. Environmental precautions: Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. Methods and materials for containment and cleaning up: Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal.
Liquid material spills can be copiously flushed with water and channeled to a treatment system or holding tank for reclamation or proper disposal. Spills of dry material can be removed by vacuuming or wet mopping. Some spills can be removed by hosing, first with a mist of water to dampen the spilled material and then with a more forceful stream that flushes it into a holding tank or other facility for handling contaminated water. Work surfaces or contaminated clothing should never be cleaned by dry sweeping or blowing with pressurized hoses. Recovery systems used to reclaim waste metals should comply with federal, state, and local regulations. All waste materials generated in the handling of cobalt-containing substances should be disposed of in compliance with federal, state, and local regulations. /Cobalt and cobalt salts/
SRP: Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in air, soil or water; effects on animal, aquatic and plant life; and conformance with environmental and public health regulations. If it is possible or reasonable use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination.
Product Offer: surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional waste disposal service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Contaminated packaging: Dispose of as unused product.
Personal protection: particulate filter respirator adapted to the airborne concentration of the substance. Sweep spilled substance into covered containers. If appropriate, moisten first to prevent dusting. Carefully collect remainder. Then store and dispose of according to local regulations.
The worker should immediately wash the skin when it becomes contaminated. /Cobalt metal dust and fume (as Co)/
Work clothing that becomes wet or significantly contaminated should be removed and replaced. /Cobalt metal dust and fume (as Co)/
Workers whose clothing may have become contaminated should change into uncontaminated clothing before leaving the work premises. /Cobalt metal dust and fume (as Co)/
ACCIDENTAL RELEASE MEASURES: Personal precautions, protective equipment and emergency procedures: Wear respiratory protection. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust. Environmental precautions: Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided.
For more Preventive Measures (Complete) data for Cobaltous oxide (13 total), please visit the HSDB record page.
Prolonged exposure (3-4 months) of rats and rabbits to mixed cobalt oxides (0.4-9 mg cobalt/mg) resulted in lesions in the alveolar region of the respiratory tract characterized histologically by nodular accumulation of Type II epithelial cells, accumulations of enlarged highly vacuolated macrophages, interstitial inflammation, and fibrosis.
... Fibrosarcomas were induced in mice 6 months after the parenteral injection of an industrial refining dust containing cobalt oxide and cobalt sulfide. /Dust containing cobalt oxide and cobalt sulfide/
ATMOSPHERIC FATE: Inorganic cobalt compounds are nonvolatile and released into the atmosphere in particulate form(1). Particulate-phase cobalt compounds are removed from the air by wet and dry deposition(SRC). Cobalt has been detected in atmospheric deposition(2) and in rain-snow precipitation(3).
The substance can be absorbed into the body by inhalation of its aerosol and by ingestion.
Inhalation (L29) ; oral (L29) ; dermal (L29)
IDENTIFICATION AND USE: Cobalt oxide is found in two forms, CoO and Co2O3. The commercial oxides are usually not definite chemical compounds but mixtures of the cobalt oxides. It could be found in the form of powder or cubic or hexagonal crystals; color varies from olive green to red depending on particle size, but the commercial material is usually dark gray. Cobalt oxide is used in pigments for ceramics, in glass coloring and decolorization, as oxidation catalyst for drying oils, and fast-drying paints and varnishes, in preparation of cobalt-metal catalysts, and cobalt powder for binder in sintered tungsten carbide; in semiconductors. HUMAN EXPOSURE AND TOXICITY: Three cases of pneumoconiosis in the tungsten carbide tool industry were reported, where exposure to cobalt powder, oxide or salt led to disease in three out of 1500 exposed workers. Particulate cobalt oxide was cytotoxic and genotoxic to human lung epithelial cells. ANIMAL STUDIES: Hamsters exposed by inhalation to cobalt oxide for a lifetime developed emphysema, but the incidence of pulmonary tumors was not different from controls. Cobalt oxide and cobalt sulfide were administered by single intramuscular injection in rats and mice and the sulfide was found to be more carcinogenic than the oxide. The carcinogenic response on injection in mice was much lower. In a later study, intramuscular injection of CoO resulted in a 50% incidence of rhabdomyosarcomas in rats but was completely negative in mice. Prolonged exposure (3-4 months) of rats and rabbits to mixed cobalt oxides (0.4-9 mg cobalt/mg) resulted in lesions in the alveolar region of the respiratory tract characterized histologically by nodular accumulation of Type II epithelial cells, accumulations of enlarged highly vacuolated macrophages, interstitial inflammation, and fibrosis. ECOTOXICITY STUDIES: Exposure to cobalt oxide (CoO <100 nm) nanoparticles was toxic to zooplankton, which is an important source of food in aquatic food chain.
Cobalt is believed to exhibit its toxicity through a oxidant-based and free radical-based processes. It produces oxygen radicals and may be oxidized to ionic cobalt, causing increased lipid peroxidation, DNA damage, and inducing certain enzymes that lead to cell apoptosis. Cobalt has also been shown to block inorganic calcium channels, possibly impairing neurotransmission. Cobalt can also chelate lipoic acids, impairing oxidation of pyruvate or fatty acids. In addition, cobalt may inhibit DNA repair by interacting with zinc finger DNA repair proteins, and has also been shown to inhibit heme synthesis and glucose metabolism. Cobalt may activate specific helper T-lymphocyte cells and interact directly with immunologic proteins, such as antibodies (IgA and IgE) or Fc receptors, resulting in immunosensitization. (L29)
/AQUATIC SPECIES/ In this study, the effects of exposure to engineered nickel oxide (NiO 40-60 nm) and cobalt oxide (CoO <100 nm) nanoparticles (NP) were investigated on Artemia salina. Aggregation and stability of the aqueous NP suspensions were characterized by DLS and TEM. Acute exposure was conducted on nauplii (larvae) in seawater in a concentration range from 0.2 to 50 mg/L NPs for 24 hr (short term) and 96 hr (long term). The hydrodynamic diameters of NiO and CoO NPs in exposure medium were larger than those estimated by TEM. Accumulation rate of NiO NPs were found to be four times higher than that of CoO NPs under the same experimental conditions. Examinations under phase contrast microscope showed that the nanoparticles accumulated in the intestine of artemia, which increased with increasing exposure concentration. Differences were observed in the extent of dissolution of the NPs in the seawater. The CoO NPs dissolved significantly while NiO NPs were relatively more stable. Oxidative stress induced by the NP suspensions was measured by malondialdehyde assay. Suspensions of NiO NPs caused higher oxidative stress on nauplii than those of CoO NPs. The results imply that CoO and NiO NPs exhibit toxicity on Artemia (e.g., zooplankton) that are an important source of food in aquatic food chain. /Cobalt oxide nanoparticles/
Cough. Sore throat. Laboured breathing. Shortness of breath.
Redness. Pain.
Abdominal pain. Nausea.
Cobalt inhalation can cause asthma-like breathing problems. Skin contact is known to result in contact dermatitis, which is characterized by irritation and rashes. Ingesting large amounts of cobalt may cause nausea and vomiting. (L2090)
The aim of this study was to verify the relationship between the cobalt oxide concentration in air and the cobalt concentration in urine. In the first study, we measured the cobalt concentration in the urine of 16 workers exposed to cobalt oxide in a Digital Video Cassette manufacturing plant at the beginning and end of their workshift during 2 working cycles. In the second study, we measured the exposure level to cobalt oxide and the cobalt concentration in urine at the end of the workshift of other 16 workers on 3 out of 5 consecutive work days (Monday, Wednesday and Friday). Four workers among the 16 participated twice. In the first study, the cobalt concentration in the urine increased about 1.5-3 fold during each workshift and then tended to decrease rapidly to the control value before the next workshift. In the second study, we examined the relationship between air and urine concentration using 22 samples after excluding data from workers with dust respirators. Comparing the air and urine concentrations for samples under 30 ug/cu m (n = 20), a significant correlation was found (r = 0.76). These results indicate that most of the inhaled cobalt oxide was excreted rapidly, and a good relationship was found between air and urine concentrations at the end of the workshift when the exposure level was under 30 ug/cu m. Therefore, the cobalt concentration in urine at the end of a workshift can be used as an indicator of one-day exposure to cobalt oxide when the exposure is low level.
It was recommended that thyroid function, blood sugar levels, and kidney function be monitored in workers exposed to cobalt compounds, particularly cobalt oxides.
Cobaltous oxide was detected in meteorites collected from Monturaqui meteorite crater in the Andes Mountains, Chile(1); the CoO content varied from 0.2 to 0.8% wt with a mean of 0.5% wt(1).
Cobaltous oxide's production and use as a pigment in ceramics, paints and varnishes, in glass coloring and decorating and as a precursor for the production of cobalt chemicals and catalysts(1,2) may result in its release to the environment through various waste streams(SRC). Release to the environment of cobaltous oxide is likely to occur from: indoor use in long-life materials with low release rate (e.g. flooring, furniture, toys, construction materials, curtains, foot-wear, leather products, paper and cardboard products, electronic equipment) and outdoor use in long-life materials with low release rate (e.g. metal, wooden and plastic construction and building materials(3).
Trace minerals added to animal feeds. These substances added to animal feeds as nutritional dietary supplements are generally recognized as safe when added at levels consistent with good feeding practice. All substances listed may be in anhydrous or hydrated form. Cobalt oxide is included on this list.
Listed as a hazardous air pollutant (HAP) generally known or suspected to cause serious health problems. The Clean Air Act, as amended in 1990, directs EPA to set standards requiring major sources to sharply reduce routine emissions of toxic pollutants. EPA is required to establish and phase in specific performance based standards for all air emission sources that emit one or more of the listed pollutants. Cobaltous oxide is included on this list.
Cobalt is absorbed though the lungs, gastrointestinal tract, and skin. Since it is a component of the vitamin B12 (cyanocobalamin), it is distributed to most tissues of the body. It is transported in the blood, often bound to albumin, with the highest levels being found in the liver and kidney. Cobalt is excreted mainly in the urine and faeces. (L29)
The aim of this study was to verify the relationship between the cobalt oxide concentration in air and the cobalt concentration in urine. In the first study, we measured the cobalt concentration in the urine of 16 workers exposed to cobalt oxide in a Digital Video Cassette manufacturing plant at the beginning and end of their workshift during 2 working cycles. In the second study, we measured the exposure level to cobalt oxide and the cobalt concentration in urine at the end of the workshift of other 16 workers on 3 out of 5 consecutive work days (Monday, Wednesday and Friday). Four workers among the 16 participated twice. In the first study, the cobalt concentration in the urine increased about 1.5-3 fold during each workshift and then tended to decrease rapidly to the control value before the next workshift. In the second study, we examined the relationship between air and urine concentration using 22 samples after excluding data from workers with dust respirators. Comparing the air and urine concentrations for samples under 30 ug/cu m (n = 20), a significant correlation was found (r = 0.76). These results indicate that most of the inhaled cobalt oxide was excreted rapidly, and a good relationship was found between air and urine concentrations at the end of the workshift when the exposure level was under 30 ug/cu m. Therefore, the cobalt concentration in urine at the end of a workshift can be used as an indicator of one-day exposure to cobalt oxide when the exposure is low level.
The 24-hr deposition and clearence in hamsters exposed by inhalation and gavage to CoO showed that 87% was distributed throughout the body form an inhaled dose of 784 ug and 11.3%, form a 5-mg dose by gavage. The greatest amounts from both routes (60 and 11% respectively) remained in the gastrointestinal tract. The carcass retained the next largest amounts, 23% from inhalation and 0.34% by gavage; the lung, 3.3% by inhalation and less than 0.06 by gavage. The liver and kidneys had small fractional percentages of the administered dose.
Three beagle dogs were exposed to 60Co3O4 /cobaltosic oxide/ and sacrificed singly at 8, 64 and 128 days. Three beagle dogs were exposed to 60CoO /cobaltous oxide/ and sacrificed at 8, 16 and 64 days after exposure. Whole-body retention patterns showed that 60CoO left the body with a shorter effective half life than 60Co3O4. The concentration of 60Co detected in the blood was at least an order of magnitude higher in the dogs exposed to 60CoO than in the dogs exposed to 60Co3O4. Cobalt-60 translocated from the lung accumulated predominantly in the kidney, liver, skeleton and cartilagenous structures such as the trachea. Higher concentrations were reached earlier in the dogs exposed to 60CoO. After early fecal excretion of material deposited in the upper respiratory tract, excretion was greatest via the urine. The higher solubility of the 60CoO formed at 1400 °C relative to 60Co3O4 formed at 850 °C is noteworthy considering that generally aerosols formed at higher temperatures are more insoluble than aerosols formed at lower temperatures /Cobaltosic and cobaltous oxides/.
Cobalt concentration from processing cobalt oxide in urine: mean: 0.34 mg/L; range: 0.1-0.9 mg/L /From table/
For more Absorption, Distribution and Excretion (Complete) data for Cobaltous oxide (6 total), please visit the HSDB record page.
Used in catalysts, dryers, waste-gas scavengers, feed additives, tungsten carbide, semiconductors, enamel coatings, and pigments for ceramics and glass; [HSDB]
Semiconductor Manufacturing [Category: Industry]
Ceramics making [Category: Hobbies]
In pigments for ceramics; glass coloring and decolorization; oxidation catalyst for drying oils, fast-drying paints and varnishes; preparation of cobalt-metal catalysts, cobalt powder for binder in sintered tungsten carbide; in semiconductors.
Use in enamel coatings on steel to improve the adherence of the enamel to the metal.
Pigment in paints and ceramics, preparation of cobalt salts, catalyst, porcelain enamels, coloring glass, feed additive, cobalt metal powder.
2023: 1,000,000 - <2,500,000 lb
Non-confidential 2012 Chemical Data Reporting (CDR) information on the production and use of chemicals manufactured or imported into the United States. Chemical: Cobalt oxide. National Production Volume: 1,385,848 lb/yr.
Calcination of cobalt carbonate or its oxides at high temperature in a neutral or slightly reducing atmosphere.
Cobalt(II) oxide, ... is usually prepared by the controlled oxidation of the metal above 900 °C followed by cooling in a protective atmosphere to prevent partial oxidation to Co3O4 /cobalt(II) dicobalt(III) tetroxide/.
Oxides of cobalt are produced from filtrate by addition of sodium carbonate, leaching in ammonium chloride solution & reduction to metal by heating in hydrogen at temperature of 1000 °C. /Cobalt oxides/
The commercial oxides are usually not definite chemical compounds but mixtures of the cobalt oxides.
Powder, (-324 mesh); metallurgical grade, 76% cobalt; ceramic grade, 70-71% Cobalt; -325 mesh, 99.5% purity grade; high purity powder grades; reagent grade
Grade: techincal, ceramic.
Cobalt fume and dust have the composition Co/CoO/Co2O2/Co2O4.
All Other Basic Inorganic Chemical Manufacturing
Cobalt oxide (CoO): ACTIVE
... Cobalt oxide iron pellets have been placed in the reticulorumen to provide slow release of cobalt. ... A steel core pellet covered with cobalt oxide-impregnated cotton gauze has been devised as a means of cobalt supplementation. As the cotton is digested by rumen microbes, cobalt is released.
BeschreibungThis is obtained as an olive-green powder by heating the metal in air or steam or by thermal decomposition of the hydroxide, carbonate or nitrate. It has the sodium chloride lattice and is antiferromagnetic below 292°K. When heated in oxygen above 400° the black oxide Co3O4 is obtained. This oxide is isomorphous with magnetite Fe3O4, and has tetrahedrally surrounded cobalt(II) ions and octahedrally surrounded cobalt(III) ions. Both these oxides are readily reduced to the metal by heating in hydrogen or with carbon. The reactions of CoO with silica, alumina and zinc oxide are used to form pigments in the ceramic industry.
VerwendenIn pigments for ceramics; glass coloring and decolorization; oxidation catalyst for drying oils, fast-drying paints and varnishes; preparation of cobalt-metal catalysts, Co powder for binder in sintered tungsten carbide; in semiconductors.